Observational study on Bicuspid Aortic Valve characteristics
Multicentre Retrospective Analysis of the Characteristics and the Long-term Prognosis of the Bicuspid Aortic Valve
This study looks at the characteristics and outcomes of Bicuspid Aortic Valve in Asian patients to see how it affects their treatment and management over time.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1000 (estimated) |
| Sex | All |
| Sponsor | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School Academic / other |
| Locations | 1 site (Nanjing, Jiangsu) |
| Trial ID | NCT05818722 on ClinicalTrials.gov |
What this trial studies
This multicentre retrospective study focuses on Bicuspid Aortic Valve (BAV), a common congenital heart condition. It aims to analyze the clinical features, long-term progression, and surgical outcomes of BAV in Asian populations, which exhibit different morphological characteristics compared to Western populations. The study will collect data from patients diagnosed with BAV through echocardiography or other imaging methods between December 2021 and October 2022 at several hospitals in Nanjing. By examining clinical symptoms, surgical interventions, and follow-up results, the study seeks to improve treatment and management strategies for affected patients.
Who should consider this trial
Good fit: Ideal candidates for this study are patients diagnosed with Bicuspid Aortic Valve through echocardiography between December 2021 and October 2022.
Not a fit: Patients whose Bicuspid Aortic Valve diagnosis is unclear or not confirmed by echocardiography and cardiac surgery may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the understanding and treatment of Bicuspid Aortic Valve in Asian patients, leading to better clinical outcomes.
How similar studies have performed: While studies on Bicuspid Aortic Valve exist, this specific focus on the Asian population's morphological differences is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * All patients with a suspected diagnosis of Bicuspid Aortic Valve by echocardiogram from December 2021 to October 2022 Exclusion Criteria: * Patients with suspected Bicuspid Aortic Valve not clearly diagnosed by echocardiography and not confirmed by cardiac surgery
Where this trial is running
Nanjing, Jiangsu
- Affiliated Drum Tower Hospital of Nanjing University Medical School — Nanjing, Jiangsu, China (Recruiting)
Study contacts
- Study coordinator: Jing Yao, Phd
- Email: w1835199709@163.com
- Phone: +8618905188727
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.